Such a trial will take at least 3 months to complete; by then, we will have (interim) results from both our mild/moderate and severe trials.

I see it as a nice PR strategy and gesture, but leronlimab will be approved and become SOC, especially if we can show a clear mortality benefit, which remdesivir failed thus far.